Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated NSCLC Patients

NCT04566432 · clinicaltrials.gov ↗

RECRUITING

Status

250

Enrollment

INDUSTRY

Sponsor class

Conditions

Lung Neoplasms
Lung Cancer, Nonsmall Cell
Adenocarcinoma of Lung
Squamous Cell Lung Cancer

Interventions

OTHER: Observation

Sponsor

Geneplus-Beijing Co. Ltd.

Collaborators

[object Object]